RNTX
$1.42
Market ClosedAs of Mar 17, 8:00 PM UTC
Rein Therapeutics Inc., a biopharmaceutical company, focuses on developing medicines to address unmet medical needs in orphan pulmonary and fibrosis indications in the United States.
Intraday
Custom Range:to
No data available for this range. Intraday data may be limited by the exchange.